|
CA2263063C
(en)
|
1999-02-26 |
2004-08-10 |
Skye Pharmatech Incorporated |
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
|
|
US6780606B1
(en)
|
1999-02-26 |
2004-08-24 |
Synx Pharma, Inc. |
Method for diagnosing and distinguishing stroke and diagnostic devices for use therein
|
|
US20030077590A1
(en)
|
2000-09-22 |
2003-04-24 |
Pedersen Finn Skou |
Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin
|
|
WO2002024867A2
(en)
|
2000-09-22 |
2002-03-28 |
University Of Aarhus |
Novel compositions and methods for lymphoma and leukemia
|
|
US6884591B2
(en)
|
2001-06-25 |
2005-04-26 |
The Cleveland Clinic Foundation |
Peripheral marker of blood brain barrier permeability
|
|
US7144708B2
(en)
|
2001-06-25 |
2006-12-05 |
The Cleveland Clinic Foundation |
Markers of blood barrier disruption and methods of using same
|
|
DE60233949D1
(de)
|
2001-08-20 |
2009-11-19 |
Biosite Inc |
Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
|
|
US20030040660A1
(en)
|
2001-08-27 |
2003-02-27 |
George Jackowski |
Method for diagnosing and distinguishing traumatic brain injury and diagnostic devices for use therein
|
|
US20070098728A1
(en)
|
2001-09-24 |
2007-05-03 |
Pedersen Finn S |
Novel compositions and methods in cancer
|
|
AU2004216925B2
(en)
|
2003-03-07 |
2010-04-22 |
London Health Sciences Centre Research Inc. |
Peptides associated with HLA-DR MHC class II molecules involved in autoimmune diseases
|
|
EP1519194A1
(en)
|
2003-09-24 |
2005-03-30 |
Roche Diagnostics GmbH |
Use of gfap for identification of intracerebral hemorrhage
|
|
US8492107B2
(en)
|
2004-04-15 |
2013-07-23 |
University Of Florida Research Foundation, Inc. |
Neural proteins as biomarkers for nervous system injury and other neural disorders
|
|
EP1745149A4
(en)
|
2004-04-15 |
2008-08-06 |
Univ Florida |
NEURALE PROTEINS AS BIOMARKERS FOR INJURY TO THE NERVOUS SYSTEM AND OTHER NEURAL DISORDERS
|
|
US20140303041A1
(en)
|
2004-04-15 |
2014-10-09 |
University Of Florida Research Foundation Inc. |
In vitro diagnostic devices for nervous system injury and other neural disorders
|
|
WO2005113798A2
(en)
|
2004-04-15 |
2005-12-01 |
University Of Florida Research Foundation, Inc. |
Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
|
|
WO2006012351A2
(en)
|
2004-06-25 |
2006-02-02 |
Washington University |
Markers for brain damage
|
|
EP1828403B1
(en)
|
2004-12-04 |
2014-08-20 |
Los Alamos National Security, LLC |
Protein subcellular localization assays using split fluorescent proteins
|
|
US20060257943A1
(en)
|
2005-01-25 |
2006-11-16 |
Cis Biotech, Inc. |
Ischemic biomarkers and their use to predict adverse neurological events from surgery
|
|
US7884260B2
(en)
|
2005-06-14 |
2011-02-08 |
University Of Chicago |
Cell-based screen for agents useful for reducing neuronal demyelination or promoting neuronal remyelination
|
|
GB2428240A
(en)
|
2005-07-14 |
2007-01-24 |
Univ Gen Ve |
Diagnostic method for brain damage-related disorders
|
|
US20080026485A1
(en)
*
|
2006-04-18 |
2008-01-31 |
Wolfgang Hueber |
Antibody profiling for determination of patient responsiveness
|
|
WO2007136617A2
(en)
|
2006-05-18 |
2007-11-29 |
Walter Reed Army Institute Of Research (Wrair) |
Endothelial-monocyte activating polypeptide ii, a biomarker for use in diagnosis of brain injury
|
|
WO2008046509A1
(en)
|
2006-10-16 |
2008-04-24 |
Bayer Schering Pharma Aktiengesellschaft |
Ltbp2 as a biomarker, therapeutic and diagnostic target
|
|
JP2008157905A
(ja)
|
2006-12-25 |
2008-07-10 |
Hectef Standard Reference Center Foundation |
添加法による生体試料中蛋白・ペプチドの定量方法
|
|
WO2008097618A1
(en)
|
2007-02-06 |
2008-08-14 |
University Of Florida Research Foundation, Inc. |
Synaptotagmin and collapsin response mediator protein as biomarkers for traumatic brain injury
|
|
JP5305259B2
(ja)
|
2007-12-25 |
2013-10-02 |
地方独立行政法人東京都健康長寿医療センター |
抗シトルリン化ｇｆａｐモノクローナル抗体及びその用途
|
|
CA2715248A1
(en)
|
2008-02-04 |
2009-08-13 |
Banyan Biomarkers, Inc. |
Process to diagnose or treat brain injury
|
|
EP2294425B1
(en)
|
2008-05-23 |
2013-05-22 |
The Johns Hopkins University |
Biomarkers for myocardial ischemia
|
|
EP2143735A1
(en)
|
2008-07-10 |
2010-01-13 |
Institut Pasteur |
Variable domains of camelid heavy-chain antibodies directed against glial fibrillary acidic proteins
|
|
US20140342381A1
(en)
|
2008-08-11 |
2014-11-20 |
Banyan Biomarkers, Inc. |
Devices and methods for biomarker detection process and assay of neurological condition
|
|
EP3336551B1
(en)
*
|
2008-08-11 |
2023-05-31 |
Banyan Biomarkers, Inc. |
Biomarker detection process and assay of neurological condition
|
|
US8119694B2
(en)
|
2008-08-15 |
2012-02-21 |
Arcion Therapeutics, Inc. |
High concentration local anesthetic formulations
|
|
US9063148B2
(en)
|
2008-10-22 |
2015-06-23 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicince, Inc. |
Immunoassays for citrullinated proteins
|
|
US20170315136A9
(en)
|
2009-06-19 |
2017-11-02 |
Banyan Biomarkers, Inc. |
Biomarker assay of neurological condition
|
|
JP5875514B2
(ja)
|
2009-06-19 |
2016-03-02 |
バンヤン・バイオマーカーズ・インコーポレーテッド |
神経学的状態のバイオマーカーアッセイ
|
|
US10266585B2
(en)
|
2009-08-28 |
2019-04-23 |
The Board Of Regents Of The Univerity Of Texas System |
Methods of treating brain injury
|
|
EP2470211B1
(en)
|
2009-08-28 |
2016-01-27 |
The Board of Regents of The University of Texas System |
Antibodies that bind tau oligomers
|
|
AU2010291933B2
(en)
|
2009-09-14 |
2016-09-08 |
Banyan Biomarkers, Inc. |
Micro-RNA, autoantibody and protein markers for diagnosis of neuronal injury
|
|
GB201008541D0
(en)
|
2010-05-21 |
2010-07-07 |
Univ Geneve |
Diagnostic methods
|
|
WO2012051519A2
(en)
*
|
2010-10-14 |
2012-04-19 |
The Johns Hopkins University |
Biomarkers of brain injury
|
|
AU2012211328A1
(en)
|
2011-01-28 |
2013-09-19 |
Cyrex Laboratories, Llc |
Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
|
|
EP2707389B1
(en)
|
2011-05-12 |
2019-10-30 |
The Johns Hopkins University |
Assay reagents for a neurogranin diagnostic kit
|
|
WO2012170998A1
(en)
|
2011-06-10 |
2012-12-13 |
Cornell University |
Immobilized protein system for rapid and enhanced multiplexed diagnostics
|
|
WO2013138509A1
(en)
*
|
2012-03-13 |
2013-09-19 |
The Johns Hopkins University |
Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
|
|
WO2013173596A1
(en)
|
2012-05-16 |
2013-11-21 |
Trustees Of Boston University |
Chronic traumatic encephalopathy in blast-exposed individuals
|
|
US20150141528A1
(en)
|
2013-05-31 |
2015-05-21 |
Banyan Biomarkers, Inc. |
Neural specific s100b for biomarker assays and devices for detection of a neurological condition
|
|
EP3022322A4
(en)
|
2013-07-17 |
2017-05-17 |
The Johns Hopkins University |
A multi-protein biomarker assay for brain injury detection and outcome
|
|
WO2015066211A1
(en)
|
2013-10-29 |
2015-05-07 |
Banyan Biomarkers, Inc. |
Uch-l1 isoforms, assays and devices for detection of a neurological condition
|
|
US10725054B2
(en)
|
2014-04-08 |
2020-07-28 |
University Of Florida Research Foundation, Incorporated |
Protein biomarkers for acute, subacute and chronic traumatic injuries of the central nervous system
|
|
EP3702786A1
(en)
|
2014-10-06 |
2020-09-02 |
Université de Genève |
Markers and their use in brain injury
|
|
EP3029466A1
(en)
|
2014-12-03 |
2016-06-08 |
Fundació Hospital Universitari Vall d' Hebron - Institut de Recerca |
Methods for differentiating ischemic stroke from hemorrhagic stroke
|
|
CA2992343A1
(en)
|
2015-07-13 |
2017-01-19 |
University Of Geneva |
Biomarker panels for brain injury complications
|